Xu X - Search Results

1

Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.

Wong BK, Sahly Y, Mistry G, Waldman S, Musson D, Majumdar A, Xu X, Yu S, Lin JH, Singh R, Holland S. Wong BK, et al. Among authors: xu x. Xenobiotica. 2004 Apr;34(4):379-89. doi: 10.1080/00498250410001670643. Xenobiotica. 2004. PMID: 15268982 Clinical Trial.

2

Improved oral absorption of L-365,260, a poorly soluble drug.

Lin JH, Storey DE, Chen IW, Xu X. Lin JH, et al. Among authors: xu x. Biopharm Drug Dispos. 1996 Jan;17(1):1-15. doi: 10.1002/(SICI)1099-081X(199601)17:1<1::AID-BDD934>3.0.CO;2-G. Biopharm Drug Dispos. 1996. PMID: 8991487

3

Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans.

Chiba M, Xu X, Nishime JA, Balani SK, Lin JH. Chiba M, et al. Among authors: xu x. Drug Metab Dispos. 1997 Sep;25(9):1022-31. Drug Metab Dispos. 1997. PMID: 9311616

4

Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.

Balani SK, Xu X, Pratha V, Koss MA, Amin RD, Dufresne C, Miller RR, Arison BH, Doss GA, Chiba M, Freeman A, Holland SD, Schwartz JI, Lasseter KC, Gertz BJ, Isenberg JI, Rogers JD, Lin JH, Baillie TA. Balani SK, et al. Among authors: xu x. Drug Metab Dispos. 1997 Nov;25(11):1282-7. Drug Metab Dispos. 1997. PMID: 9351905 Clinical Trial.

5

In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism.

Prueksaritanont T, DeLuna P, Gorham LM, Ma B, Cohn D, Pang J, Xu X, Leung K, Lin JH. Prueksaritanont T, et al. Among authors: xu x. Drug Metab Dispos. 1998 Jun;26(6):520-7. Drug Metab Dispos. 1998. PMID: 9616186

6

Montelukast dose selection in 6- to 14-year-olds: comparison of single-dose pharmacokinetics in children and adults.

Knorr B, Larson P, Nguyen HH, Holland S, Reiss TF, Chervinsky P, Blake K, van Nispen CH, Noonan G, Freeman A, Haesen R, Michiels N, Rogers JD, Amin RD, Zhao J, Xu X, Seidenberg BC, Gertz BJ, Spielberg S. Knorr B, et al. Among authors: xu x. J Clin Pharmacol. 1999 Aug;39(8):786-93. doi: 10.1177/00912709922008434. J Clin Pharmacol. 1999. PMID: 10434229 Clinical Trial.

7

Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor library.

Rano TA, Cheng Y, Huening TT, Zhang F, Schleif WA, Gabryelski L, Olsen DB, Kuo LC, Lin JH, Xu X, Olah TV, McLoughlin DA, King R, Chapman KT, Tata JR. Rano TA, et al. Among authors: xu x. Bioorg Med Chem Lett. 2000 Jul 17;10(14):1527-30. doi: 10.1016/s0960-894x(00)00276-6. Bioorg Med Chem Lett. 2000. PMID: 10915042

8

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.

Balani SK, Xu X, Arison BH, Silva MV, Gries A, DeLuna FA, Cui D, Kari PH, Ly T, Hop CE, Singh R, Wallace MA, Dean DC, Lin JH, Pearson PG, Baillie TA. Balani SK, et al. Among authors: xu x. Drug Metab Dispos. 2000 Nov;28(11):1274-8. Drug Metab Dispos. 2000. PMID: 11038152

9

Stereoselective hepatic disposition of a diastereomeric pair of alphavbeta3 antagonists in rat.

Prueksaritanont T, Xu X, Deluna P, Yamazaki M, Lin JH. Prueksaritanont T, et al. Among authors: xu x. Xenobiotica. 2003 Nov;33(11):1125-37. doi: 10.1080/00498250310001609174. Xenobiotica. 2003. PMID: 14660176

10

[Isolation and structure identification of chemical constituents from Viscum liquidambaricolum].

Yang YJ, Lin JH, Xu XW. Yang YJ, et al. Yao Xue Xue Bao. 2005 Apr;40(4):351-4. Yao Xue Xue Bao. 2005. PMID: 16011265 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,452 results

Search Page

Filters